APLS icon

Apellis Pharmaceuticals
APLS

Overview Fund Activity

243 hedge funds and large institutions have $5.19B invested in Apellis Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 96 increasing their positions, 83 reducing their positions, and 40 closing their positions.

Holders
243
Holders Change
-6
Holders Change %
-2.41%
% of All Funds
3.92%
Holding in Top 10
12
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+20%
% of All Funds
0.19%
New
36
Increased
96
Reduced
83
Closed
40
Calls
$81.6M
Puts
$55.8M
Net Calls
+$25.8M
Net Calls Change
+$45.2M

Top Buyers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$206M
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$95.5M
3
Westfield Capital Management
3
Westfield Capital Management
Massachusetts
$35.7M
4
OCA
4
Octagon Capital Advisors
New York
$163M
5
BlackRock
5
BlackRock
New York
$398M

Top Sellers

1
Viking Global Investors
1
Viking Global Investors
Connecticut
$0
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$453M
3
APM
3
Avidity Partners Management
Texas
$0
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$142M
5
DCM
5
Driehaus Capital Management
Illinois
$15.2M
Name Market Value Shares Shares
Change 		Shares
Change %
ACA
1
Avoro Capital Advisors
New York
$549M 10,625,000 +500,000 +5%
Vanguard Group
2
Vanguard Group
Pennsylvania
$476M 9,212,491 +181,412 +2%
Wellington Management Group
3
Wellington Management Group
Massachusetts
$453M 8,757,661 -1,199,755 -12%
BlackRock
4
BlackRock
New York
$398M 7,704,194 +617,864 +9%
T. Rowe Price Investment Management
5
T. Rowe Price Investment Management
Maryland
$302M 5,842,660 +326,537 +6%
EC
6
EcoR1 Capital
California
$268M 5,183,431 – –
Janus Henderson Group
7
Janus Henderson Group
United Kingdom
$206M 3,987,745 +3,959,473 +14,005%
State Street
8
State Street
Massachusetts
$180M 3,471,914 +514,641 +17%
OCA
9
Octagon Capital Advisors
New York
$163M 3,160,000 +656,941 +26%
T. Rowe Price Associates
10
T. Rowe Price Associates
Maryland
$142M 2,749,542 -601,421 -18%
Jennison Associates
11
Jennison Associates
New York
$130M 2,515,317 -19,395 -0.8%
JPMorgan Chase & Co
12
JPMorgan Chase & Co
New York
$95.5M 1,847,309 +907,262 +97%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$90.5M 1,750,001 +58,799 +3%
CAM
14
Cormorant Asset Management
Massachusetts
$81.5M 1,576,872 +98,872 +7%
BC
15
Boxer Capital
California
$81.5M 1,576,000 +272,300 +21%
Macquarie Group
16
Macquarie Group
Australia
$75.6M 1,461,642 +40,107 +3%
Fidelity Investments
17
Fidelity Investments
Massachusetts
$75.5M 1,460,163 -1 -0%
LGM
18
Logos Global Management
California
$69.8M 1,350,000 +50,000 +4%
Lord, Abbett & Co
19
Lord, Abbett & Co
New Jersey
$58.6M 1,132,623 +186,097 +20%
BG
20
Bellevue Group
Switzerland
$57.1M 1,104,217 +96,773 +10%
Goldman Sachs
21
Goldman Sachs
New York
$54.9M 1,061,703 +104,025 +11%
Norges Bank
22
Norges Bank
Norway
$54.2M 1,047,454 +74,480 +8%
Charles Schwab
23
Charles Schwab
California
$50.8M 982,927 +34,168 +4%
AG
24
Artal Group
Luxembourg
$46.5M 900,000 -100,000 -10%
Northern Trust
25
Northern Trust
Illinois
$44.3M 857,121 +7,933 +0.9%
1
2 3 4 5